Treatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients
Open Access
- 1 December 2016
- journal article
- Published by Elsevier in BBA Clinical
- Vol. 6, 100-107
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Treatment of nonunions in fractures of the humeral shaft according to the Diamond ConceptThe Bone & Joint Journal, 2016
- Development of ADA Against Recombinant Human Interferon Beta in Immune Tolerant Mice Requires Rapid Recruitment of CD4+ T Cells, Induces Formation of Germinal Centers but Lacks Susceptibility for (Most) AdjuvantsJournal of Pharmaceutical Sciences, 2015
- Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeuticsJournal of Pharmaceutical and Biomedical Analysis, 2011
- Cigarette smoking decreases TGF-β1 serum concentrations after long bone fractureInjury, 2010
- Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeuticsJournal of Immunological Methods, 2007
- The Danger Model: A Renewed Sense of SelfScience, 2002
- Thrombocytopenia caused by the development of antibodies to thrombopoietinBlood, 2001
- The immune system evolved to discriminate infectious nonself from noninfectious selfImmunology Today, 1992
- Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation.Proceedings of the National Academy of Sciences, 1981
- Bone: Formation by AutoinductionScience, 1965